Visionflex Group 将来の成長

Future 基準チェック /06

We currently don't have sufficient analyst coverage to forecast growth and revenue for Visionflex Group.

主要情報

n/a

収益成長率

n/a

EPS成長率

Healthcare Services 収益成長	20.9%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

更新なし

Recent updates

How Many 1st Group Limited (ASX:1ST) Shares Did Insiders Buy, In The Last Year?

Jan 07

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Visionflex Group は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

ASX:VFX - アナリストの将来予測と過去の財務データ ( )AUD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2024	7	-2	-1	-1	N/A
12/31/2023	6	-1	-1	-1	N/A
9/30/2023	5	-2	-2	-2	N/A
6/30/2023	3	-3	-4	-4	N/A
12/31/2022	2	-6	-4	-4	N/A
9/30/2022	2	-6	-3	-3	N/A
6/30/2022	3	-5	-3	-3	N/A
3/31/2022	5	-7	-3	-3	N/A
12/31/2021	5	-7	-3	-3	N/A
9/30/2021	5	-7	-3	-3	N/A
6/30/2021	5	-6	-4	-3	N/A
3/31/2021	5	-5	-4	-4	N/A
12/31/2020	5	-4	-4	-4	N/A
9/30/2020	5	-5	-4	-4	N/A
6/30/2020	5	-5	-4	-4	N/A
3/31/2020	5	-5	-4	-4	N/A
12/31/2019	5	-5	-4	-4	N/A
9/30/2019	4	-5	-4	-4	N/A
6/30/2019	4	-4	-4	-4	N/A
3/31/2019	4	-4	-3	-3	N/A
12/31/2018	4	-4	-3	-3	N/A
9/30/2018	3	-5	-3	-3	N/A
6/30/2018	3	-5	-4	-4	N/A
3/31/2018	3	-5	N/A	-3	N/A
12/31/2017	3	-5	N/A	-3	N/A
9/30/2017	3	-5	N/A	-3	N/A
6/30/2017	2	-5	N/A	-3	N/A
3/31/2017	2	-5	N/A	-3	N/A
12/31/2016	2	-6	N/A	-3	N/A
9/30/2016	2	-5	N/A	-2	N/A
6/30/2016	2	-5	N/A	-2	N/A
3/31/2016	2	-5	N/A	-3	N/A
12/31/2015	1	-4	N/A	-3	N/A
9/30/2015	1	-4	N/A	-2	N/A
6/30/2015	0	-3	N/A	-2	N/A
6/30/2014	0	-2	N/A	-2	N/A

アナリストによる今後の成長予測

収入対貯蓄率: Insufficient data to determine if VFX's forecast earnings growth is above the savings rate (2.4%).

収益対市場: Insufficient data to determine if VFX's earnings are forecast to grow faster than the Australian market

高成長収益: Insufficient data to determine if VFX's earnings are expected to grow significantly over the next 3 years.

収益対市場: Insufficient data to determine if VFX's revenue is forecast to grow faster than the Australian market.

高い収益成長: Insufficient data to determine if VFX's revenue is forecast to grow faster than 20% per year.

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: Insufficient data to determine if VFX's Return on Equity is forecast to be high in 3 years time

Visionflex Group 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Recent updates

Visionflex Group Limited, Annual General Meeting, Oct 24, 2024

Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in FY 2023)

New major risk - Shareholder dilution

New minor risk - Shareholder dilution

Visionflex Group Limited has filed a Follow-on Equity Offering in the amount of AUD 7.084956 million.

Visionflex Group Limited Announces Executive Changes

First half 2024 earnings released: AU$0.001 loss per share (vs AU$0.003 loss in 1H 2023)

New major risk - Share price stability

Visionflex Group Limited Announces the Appointment of James Aulsebrook as Chief Financial Officer, Effective 14 February 2024

Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0.01 loss in FY 2022)

1st Group Limited, Annual General Meeting, Oct 26, 2023

Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.013 loss in FY 2022)

1ST Group Limited Appoints Michael Kafruni as New Chief Operating Officer

1ST Group Limited Appoints Michael Kafruni as New Chief Operating Officer

1st Group Limited Announces the Resignation of Richard Rogers as Chief Financial Officer and Chief Operating Officer

Healthshare Pty Ltd. completed the acquisition of MyHealth1st from 1st Group Limited (ASX:1ST).

1st Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.985453 million.

No independent directors

1st Group Limited Appoints Joshua Mundey as Chief Executive Officer

1st Group Limited Appoints Joshua Mundey as Chief Executive Officer

1St Group Limited Announces Board Changes

1st Group Limited Announces Resignation of Maggie Niewidok as Joint Company Secretary

1st Group Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.013 loss per share (vs AU$0.015 loss in FY 2021)

Full year 2022 earnings released: AU$0.013 loss per share (vs AU$0.015 loss in FY 2021)

1st Group Limited Appoints John Nantes as Director, Effective 17 June 2022

1st Group Limited Appoints Brook Adcock as Director

1st Group Limited has completed an IPO in the amount of AUD 2.5 million.

1st Group Limited, Annual General Meeting, Jun 16, 2022

No independent directors

No independent directors

1st Group Limited Appoints Maggie Niewidok as Joint Company Secretary

First half 2022 earnings: Revenues and EPS in line with analyst expectations

1st Group Limited to Report First Half, 2021 Results on Feb 28, 2022

1st Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.280417 million.

1st Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.280417 million.

1st Group Limited (ASX:1ST) entered into a share acquisition agreement Visionflex Pty Limited from Adcock Private Equity Pty Ltd, Michael Harman, Elke Harman, Peter Shandley and Vanilla Milkshake Enterprises Pty Ltd for AUD 5.8 million.

1st Group Limited Launches MyHealth1st 2.0

Full year 2021 earnings released: AU$0.015 loss per share (vs AU$0.013 loss in FY 2020)

Director Ross McCreath has left the company

Company Secretary Andrew Whitten has left the company

Independent Non-Executive Director Michael Emmett has left the company

Independent Chairman of the Board Paul Welch has left the company

Interim CEO & Director Louise McElvogue has left the company

How Many 1st Group Limited (ASX:1ST) Shares Did Insiders Buy, In The Last Year?

Full year earnings released - AU$0.013 loss per share

Full year earnings released - AU$0.013 loss per share

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘